Market Overview:
The global sunitinib malate market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, increasing awareness about cancer treatment options, and technological advancements in the field of oncology. Based on type, the global sunitinib malate market is segmented into purity levels of above 99%, 98%, and 97%. The purity level above 99% segment is expected to account for the largest share of the market during the forecast period. This can be attributed to factors such as growing demand for high-purity drugs and increasing focus on quality by manufacturers. Based on application, pancreatic neuroendocrine tumors (PNETs) are expected to account for the largest share of the global sunitinib malate market duringthe forecast period.
Product Definition:
Sunitinib malate is a drug that is used to treat cancer. It works by blocking the action of some enzymes that are found in cancer cells and it stops the cells from growing and dividing.
Purity: Above 99%:
Purity: Above 99%, it's usage.
Introduction of new technologies for the production of high purity products is expected to drive the global pharmaceutical industry over the forecast period. High purity drugs are those which have very low percentage of impurities or additives. The U.
Purity: Above 98%:
Q. What is the difference between Purity, % and Grade? A.
Application Insights:
The gastrointestinal stromal tumor segment held the largest share of the overall revenue in 2017. This can be attributed to high incidence rates of this cancer and rising awareness about sunitinib malate as a potential treatment option. In addition, manufacturers are engaged in promoting sunitinib malate for various other cancers such as pancreatic neuroendocrine tumors, kidney cancer and others which is expected to propel demand over the forecast period.
Pancreatic neuroendocrine tumors accounted for a significant share owing to their increasing incidence rates globally coupled with rising awareness about available treatment options such as chemotherapy and radiation therapy which have limited success rates resulting in fewer therapeutic choices remaining for patients suffering from this disease. This has resulted in an increased focus on alternative therapies that offer better prospects of cure thereby boosting demand over recent years among other factors contributing towards its larger market share compared to other applications within the same region or country during the same period.
Regional Analysis:
North America dominated the global sunitinib malate market in 2017. This is attributed to the presence of key companies, such as Pfizer Inc., in this region. The U.S.-based company markets its products under various brand names, such as Tarceva and Sutent. In addition, rising incidence rates of cancer have led to an increase in demand for oncology drugs that act by targeting specific proteins or molecules involved in tumor growth and development; thus increasing market penetration for sunitinib malate-based drugs acting as tyrosine kinase inhibitors (TKIs).
Asia Pacific is expected to be one of the fastest growing regions during the forecast period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure leading to an increase in awareness regarding advanced treatment options for pancreatic neuroendocrine tumors (PNECs), gastrointestinal stromal tumors (GISTs).
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for sunitinib malate in the coming years.
- Growing awareness about sunitinib malate: There is a growing awareness about the benefits of sunitinib malate among patients and healthcare professionals alike. This is likely to boost its demand in the near future.
- Rising number of clinical trials: A large number of clinical trials are being conducted on sunitinib malate across the world, which is indicative of its growing popularity among researchers and physicians alike. This will fuel its market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sunitinib Malate Market Research Report
By Type
Purity: Above 99%, Purity: Above 98%, Purity: Above 97%
By Application
Pancreatic Neuroendocrine Tumors, Kidney Cancer, Gastrointestinal stromal tumor, Others
By Companies
Pfizer, Topcarepharm, Njfirstpharm, J&K Scientific, Targetmol, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Sunitinib Malate Market Report Segments:
The global Sunitinib Malate market is segmented on the basis of:
Types
Purity: Above 99%, Purity: Above 98%, Purity: Above 97%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pancreatic Neuroendocrine Tumors, Kidney Cancer, Gastrointestinal stromal tumor, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Topcarepharm
- Njfirstpharm
- J&K Scientific
- Targetmol
- Pfizer
Highlights of The Sunitinib Malate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity: Above 99%
- Purity: Above 98%
- Purity: Above 97%
- By Application:
- Pancreatic Neuroendocrine Tumors
- Kidney Cancer
- Gastrointestinal stromal tumor
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sunitinib Malate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sunitinib malate is a cancer drug that inhibits the growth of tumors by blocking the action of proteins that promote tumor growth. Sunitinib malate is approved to treat patients with advanced or metastatic renal cell carcinoma (RCC).
Some of the key players operating in the sunitinib malate market are Pfizer, Topcarepharm, Njfirstpharm, J&K Scientific, Targetmol, Pfizer.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sunitinib Malate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sunitinib Malate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sunitinib Malate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sunitinib Malate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sunitinib Malate Market Size & Forecast, 2020-2028
4.5.1 Sunitinib Malate Market Size and Y-o-Y Growth
4.5.2 Sunitinib Malate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity: Above 99%
5.2.2 Purity: Above 98%
5.2.3 Purity: Above 97%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pancreatic Neuroendocrine Tumors
6.2.2 Kidney Cancer
6.2.3 Gastrointestinal stromal tumor
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sunitinib Malate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sunitinib Malate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity: Above 99%
9.6.2 Purity: Above 98%
9.6.3 Purity: Above 97%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pancreatic Neuroendocrine Tumors
9.10.2 Kidney Cancer
9.10.3 Gastrointestinal stromal tumor
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity: Above 99%
10.6.2 Purity: Above 98%
10.6.3 Purity: Above 97%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pancreatic Neuroendocrine Tumors
10.10.2 Kidney Cancer
10.10.3 Gastrointestinal stromal tumor
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity: Above 99%
11.6.2 Purity: Above 98%
11.6.3 Purity: Above 97%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pancreatic Neuroendocrine Tumors
11.10.2 Kidney Cancer
11.10.3 Gastrointestinal stromal tumor
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity: Above 99%
12.6.2 Purity: Above 98%
12.6.3 Purity: Above 97%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pancreatic Neuroendocrine Tumors
12.10.2 Kidney Cancer
12.10.3 Gastrointestinal stromal tumor
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity: Above 99%
13.6.2 Purity: Above 98%
13.6.3 Purity: Above 97%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pancreatic Neuroendocrine Tumors
13.10.2 Kidney Cancer
13.10.3 Gastrointestinal stromal tumor
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sunitinib Malate Market: Competitive Dashboard
14.2 Global Sunitinib Malate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Topcarepharm
14.3.3 Njfirstpharm
14.3.4 J&K Scientific
14.3.5 Targetmol
14.3.6 Pfizer
